MRA Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

MRA Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	+23,652	New	+$1.36M	0.49%	48
2025 Q1	–	Sell	-3,964	Closed	-$224K	–	133
2024 Q4	$224K	Sell	3,964 -621	-14%	-$34.7K	0.12%	95
2024 Q3	$237K	Sell	4,585 -1,303	-22%	-$61.1K	0.13%	88
2024 Q2	$245K	Buy	+5,888	New	+$263K	0.14%	84
2023 Q3	–	Sell	-4,704	Closed	-$301K	–	121
2023 Q2	$301K	Buy	4,704 +15	+0.3%	+$1.01K	0.21%	83
2023 Q1	$325K	Buy	4,689 +1,723	+58%	+$122K	0.23%	72
2022 Q4	$213K	Buy	+2,966	New	+$224K	0.17%	93
2021 Q3	–	Sell	-7,407	Closed	-$495K	–	126
2021 Q2	$495K	Sell	7,407 -558	-7%	-$36.4K	0.42%	49
2021 Q1	$503K	Buy	7,965 +898	+13%	+$55.9K	0.47%	48
2020 Q4	$438K	Buy	+7,067	New	+$435K	0.43%	55

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MRA Advisory Group's BMY Position: Q2 2026 in Review

MRA Advisory Group opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 23,652 shares worth $1.36M. The stake represents 0.49% of the portfolio and ranks #48 among its holdings. This is a return to the name: MRA Advisory Group previously reported a position in BMY as recently as Q4 2024.

MRA Advisory Group first reported a position in BMY in Q4 2020 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

MRA Advisory Group held 23,652 shares of Bristol-Myers Squibb worth $1.36M as of Q2 2026.
Bristol-Myers Squibb was a new MRA Advisory Group position in Q2 2026.
Bristol-Myers Squibb made up 0.49% of MRA Advisory Group's portfolio in Q2 2026, its #48 holding.
MRA Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 10 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.